Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-06-03 Sale | 2025-06-04 4:26 pm | NovoCure Ltd | NVCR | Stafford Kristin Director | 999 | $17.28 | $17,259 | 3,054 (Direct) | View |
| 2025-06-03 Sale | 2025-06-04 4:24 pm | NovoCure Ltd | NVCR | LEUNG GABRIEL Director | 999 | $17.31 | $17,297 | 81,229 (Direct) | View |
| 2025-06-03 Sale | 2025-06-04 4:23 pm | NovoCure Ltd | NVCR | Madden Martin J. Director | 999 | $17.19 | $17,176 | 18,674 (Direct) | View |
| 2025-06-03 Sale | 2025-06-04 4:22 pm | NovoCure Ltd | NVCR | Scannell Timothy J Director | 999 | $17.32 | $17,299 | 6,018 (Direct) | View |
| 2025-06-03 Sale | 2025-06-04 4:17 pm | NovoCure Ltd | NVCR | HILLEMAN JERYL L Director | 999 | $17.26 | $17,247 | 5,591 (Direct) | View |
| 2025-06-03 Sale | 2025-06-04 4:16 pm | NovoCure Ltd | NVCR | Ocean Allyson J Director | 999 | $17.29 | $17,269 | 3,054 (Direct) | View |
| 2025-06-03 Sale | 2025-06-04 4:14 pm | NovoCure Ltd | NVCR | VERNON W ANTHONY Director | 999 | $17.35 | $17,329 | 167,887 (Direct) | View |
| 2025-06-03 Sale | 2025-06-04 4:11 pm | NovoCure Ltd | NVCR | Hung David Director | 999 | $17.3 | $17,280 | 12,195 (Direct) | View |
| 2025-06-02 Sale | 2025-06-04 4:09 pm | NovoCure Ltd | NVCR | Leonard Frank X EVP, Pres., Novocure Oncology | 30,196 | $17.5 | $528,413 | 168,452 (Direct) | View |
| 2025-05-03 Sale | 2025-05-05 4:17 pm | NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer | 592 | $17.91 | $10,604 | 83,556 (Direct) | View |
| 2025-03-03 Sale | 2025-03-04 4:19 pm | NovoCure Ltd | NVCR | Weinberg Uri Chief Innovation Officer | 268 | $18.92 | $5,071 | 166,243 (Direct) | View |
| 2025-03-03 Sale | 2025-03-04 4:19 pm | NovoCure Ltd | NVCR | Leonard Frank X EVP, Pres., Novocure Oncology | 2,527 | $18.54 | $46,841 | 143,673 (Direct) | View |
| 2025-03-03 Sale | 2025-03-04 4:19 pm | NovoCure Ltd | NVCR | Cordova Ashley Chief Executive Officer | 2,053 | $18.54 | $38,055 | 204,005 (Direct) | View |
| 2025-03-03 Sale | 2025-03-04 4:16 pm | NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer | 250 | $18.54 | $4,634 | 29,173 (Direct) | View |
| 2025-02-28 Sale(A) | 2025-03-03 9:27 pm | NovoCure Ltd | NVCR | Weinberg Uri Chief Innovation Officer | 4,637 | $18.75 | $86,949 | 166,511 (Direct) | View |
| 2025-02-27 Sale(A) | 2025-03-03 9:26 pm | NovoCure Ltd | NVCR | Cordova Ashley Chief Executive Officer | 13,494 | $19.72 | $266,126 | 206,058 (Direct) | View |
| 2025-02-27 Sale(A) | 2025-03-03 9:26 pm | NovoCure Ltd | NVCR | Leonard Frank X EVP, Pres., Novocure Oncology | 15,036 | $19.7 | $296,257 | 146,200 (Direct) | View |
| 2025-02-27 Sale(A) | 2025-03-03 9:26 pm | NovoCure Ltd | NVCR | Puri Michal Nath Chief Human Resources Officer | 1,387 | $20.02 | $27,773 | 108,706 (Direct) | View |
| 2025-02-27 Sale(A) | 2025-03-03 9:26 pm | NovoCure Ltd | NVCR | Leupin Nicolas Chief Medical Officer | 991 | $20.02 | $19,844 | 50,133 (Direct) | View |
| 2025-02-27 Sale(A) | 2025-03-03 9:26 pm | NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer | 2,014 | $19.71 | $39,688 | 29,423 (Direct) | View |
| 2025-02-28 Sale | 2025-03-03 4:28 pm | NovoCure Ltd | NVCR | Weinberg Uri Chief Innovation Officer | 4,637 | $18.75 | $86,949 | 166,511 (Direct) | View |
| 2025-02-27 Sale | 2025-03-03 4:28 pm | NovoCure Ltd | NVCR | Leupin Nicolas Chief Medical Officer | 991 | $20.02 | $19,844 | 50,133 (Direct) | View |
| 2025-02-27 Sale | 2025-03-03 4:27 pm | NovoCure Ltd | NVCR | Puri Michal Nath Chief Human Resources Officer | 1,387 | $20.02 | $27,773 | 108,706 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-04 Option Award | 2025-06-06 4:21 pm | 2026-06-04 2035-06-04 | NovoCure Ltd | NVCR | LEUNG GABRIEL Director | 27,912 | $0 | 109,141 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:20 pm | 2026-06-04 2035-06-04 | NovoCure Ltd | NVCR | Stafford Kristin Director | 27,912 | $0 | 30,966 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:19 pm | 2026-06-04 2035-06-04 | NovoCure Ltd | NVCR | Madden Martin J. Director | 33,393 | $0 | 33,393 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:17 pm | 2026-06-04 2035-06-04 | NovoCure Ltd | NVCR | HILLEMAN JERYL L Director | 27,912 | $0 | 33,503 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:16 pm | 2026-06-04 2035-06-04 | NovoCure Ltd | NVCR | Ocean Allyson J Director | 27,912 | $0 | 30,966 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:15 pm | 2026-06-04 2035-06-04 | NovoCure Ltd | NVCR | Scannell Timothy J Director | 27,912 | $0 | 33,930 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:14 pm | 2026-06-04 2035-06-04 | NovoCure Ltd | NVCR | Hung David Director | 27,912 | $0 | 40,107 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:13 pm | 2026-06-04 2035-06-04 | NovoCure Ltd | NVCR | VERNON W ANTHONY Director | 27,912 | $0 | 195,799 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:10 pm | N/A N/A | NovoCure Ltd | NVCR | Leonard Frank X EVP, Pres., Novocure Oncology | 179,426 | $0 | 347,878 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 4:48 pm | 2026-03-04 2035-03-03 | NovoCure Ltd | NVCR | Brackmann Christoph Chief Financial Officer | 136,474 | $18.19 | 202,649 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 4:42 pm | 2026-03-04 2035-03-03 | NovoCure Ltd | NVCR | Leupin Nicolas Chief Medical Officer | 136,474 | $18.19 | 186,607 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 4:42 pm | 2026-03-04 2035-03-03 | NovoCure Ltd | NVCR | Ben Arye Barak General Counsel | 136,474 | $18.19 | 255,195 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 4:41 pm | 2026-03-04 2035-03-03 | NovoCure Ltd | NVCR | Puri Michal Nath Chief Human Resources Officer | 136,474 | $18.19 | 245,180 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 4:41 pm | 2026-03-04 2035-03-03 | NovoCure Ltd | NVCR | Weinberg Uri Chief Innovation Officer | 136,474 | $18.19 | 302,717 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 4:41 pm | 2026-03-04 2035-03-03 | NovoCure Ltd | NVCR | Leonard Frank X EVP, Pres., Novocure Oncology | 136,474 | $18.19 | 280,147 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 4:40 pm | 2026-03-04 2035-03-03 | NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer | 136,474 | $18.19 | 165,647 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 4:39 pm | 2026-03-04 2035-03-03 | NovoCure Ltd | NVCR | Cordova Ashley Chief Executive Officer | 375,304 | $18.19 | 579,309 (Direct) | View |